Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Bevacizumab, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
- Status
- UNKNOWN
- Phase
- PHASE3
Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Intravitreal Bevacizumab for Inflammatory Neovascular Membranes
- Status
- WITHDRAWN
- Phase
- PHASE3
Effect of Avastin in Juxtafoveal Telangiectasias
- Status
- WITHDRAWN
- Phase
- PHASE3
Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)
- Status
- WITHDRAWN
- Phase
- PHASE3
Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
ABI-007 and Bevacizumab in Treating Women With Recurrent or Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE)
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Bevacizumab + CHOP-Rituximab in Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2